Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment safer Ophthalmology Times Europe, 10 Aug 2022 Today, more than 50% of patients with wet age-related macular degeneration (AMD) are treated off-label with repackaged…